T1	Participants 83 144	rheumatoid arthritis patients who had no clinical improvement
T2	Participants 186 273	anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study
T3	Participants 359 440	rheumatoid arthritis (RA) patients who have not responded clinically to treatment
